Trial Profile
An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 09 Feb 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.